Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
North York General Hospital
New Research Shows Promise For Bone Marrow Transplant Recipient Patients To Reduce Treatment Side Effects!
Boston Children's Hospital
University of Tokyo Hospital - Top 10 Best Hospitals in the World
FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!
